Mayo Clinic, Phoenix, Arizona, US.
Methodist Debakey Cardiovasc J. 2024 Sep 2;20(1):80-86. doi: 10.14797/mdcvj.1414. eCollection 2024.
The WATCHMAN™ atrial appendage closure device is designed to reduce the risk of stroke in patients with nonvalvular atrial fibrillation who are not suitable candidates for long-term oral anticoagulation therapy. However, the device also carries small risks, including procedural complications such as device migration, embolization, or pericardial effusion. We describe a case of WATCHMAN device migration requiring surgical retrieval.
WATCHMAN™ 心房瓣闭合装置旨在降低不适合长期口服抗凝治疗的非瓣膜性心房颤动患者发生中风的风险。然而,该装置也存在一定的风险,包括手术并发症,如装置移位、栓塞或心包积液。我们描述了一例需要手术取出的 WATCHMAN 装置移位病例。